New Page — Spotlight Therapeutics

Spotlight Therapeutics · CRISPR Technology Turns 10, Rises to New Challenges · In aiming to bypass CRISPR's delivery issues, one startup eyes the gene editing ...

Spotlight Therapeutics

Spotlight therapeutics. In vivo gene editing. Illuminating life-changing therapeutics. Back to Top. Contact us. Spotlight Therapeutics 3980 Trust Way Hayward, ...

Science — Spotlight Therapeutics

We also are exploring an exciting new class of cell-targeted eRNPs. Taking a page from the antibody-drug conjugate playbook, we have developed ...

Presentations and posters - Spotlight Therapeutics

Spotlight Therapeutics is developing RNP-based biologics to enable gene editing of selected cell types in vivo. This new class of modular RNPs, called TAGE ( ...

Spotlight Therapeutics Raises $36.5 Million Series B to Advance a ...

A biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today announced a $36.5M Series B financing to ...

Spotlight Therapeutics Raises $36.5 Million Series B

Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, ...

Spotlight Therapeutics - Company Profile - Tracxn

What are the most recent funding rounds of Spotlight Therapeutics? Its latest funding round was a Series B round on Mar 22, 2022 for $36.5M. 5 ...

Company: Spotlight Therapeutics - CRISPR Medicine News

Spotlight Therapeutics is an early stage pre-clinical gene-editing company. Spotlight is focused on developing first-in-class in vivo gene-editing therapeutics.

Jasper Therapeutics Reports Positive Data from SPOTLIGHT

... page of Jasper's Investor Relations website. About Briquilimab ... new therapies and the willingness of physicians to prescribe these ...

Spotlight Therapeutics Company Profile: Overview and Full News ...

Antoine is a biotechnology company applying new insights to develop cell-targeted in vivo gene editing biologics . Key People Mentioned: Craig Gordon | Mary ...

Mary Haak-Frendscho - Spotlight Therapeutics | LinkedIn

Entrepreneurial biotechnology executive experienced in both private and public companies… · Experience: Spotlight Therapeutics · Education: Columbia ...

Spotlight Therapeutics - Crunchbase Company Profile & Funding

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Spotlight Therapeutics Inc. - BioCentury Company Profiles - BCIQ

Illumina names Hologic's MacMillan chair. Plus: New CEO at OBI and updates from Affini-T, Walking Fish and Bellicum ... Items per page: 10. 1 - 10 of 11.

Spotlight Therapeutics - Valuation, Funding & Investors - PitchBook

Operator of a biotechnology platform intended to develop a new class of therapeutics by direct cell-targeted in vivo gene editing.

CRISPR gene editing startup Spotlight Therapeutics raises $36.5M

The Series B round for Spotlight was co-led by new investors GordonMD Global Investments and EPIQ Capital Group. It included Magnetic ...

Startup unifies lab management to pave the way for Big Data analytics

Spotlight Therapeutics is pioneering cell-targeted in vivo CRISPR gene editing by creating a new class of programmable ribonuceloproteins called Targeted ...

Spotlight Therapeutics: making CRISPR deliver in vivo - Nature

... new thinking. Alex Marson, co-founder of Spotlight Therapeutics © Anastasiia Sapon for UCSF. “We thought there was an opportunity, based on ...

Spotlight Therapeutics Inc. - [LSUS] Life-Sciences-USA.com

Nordic-American Healthcare Conference 2025 New York (NAHC 2025) · » More ... Spotlight Therapeutics Inc. Web page https://www.spotlighttx.com. LinkedIn ...

Spotlight Therapeutics - CB Insights

Spotlight Therapeutics is a biotechnology company focused on developing a new class of therapeutics through direct in vivo gene editing.

Careers - Spotlight Therapeutics

At Spotlight Therapeutics we are committed to a supportive and collaborative workplace that recognizes and celebrates the contributions of everyone.